Literature DB >> 20657729

Identification of Chemically Sulfated/desulfated Glycosaminoglycans in Contaminated Heparins and Development of a Simple Assay for the Detection of Most Contaminants in Heparin.

Jing Pan1, Yi Qian, Xiaodong Zhou, Andrew Pazandak, Sarah B Frazier, Peter Weiser, Hong Lu, Lijuan Zhang.   

Abstract

Contaminated heparin was linked to at least 149 deaths and hundreds of adverse reactions. Published report indicates that heparin contaminants were a natural impurity, dermatan sulfate, and a contaminant, oversulfated chondroitin sulfate (OSCS). OSCS was assumed to derive from animal cartilage. By analyzing 26 contaminated heparin lots from different sources, our data indicate that the heparin contaminants were chemically sulfated or chemically sulfated/desulfated glycosaminoglycans (GAGs) consisting of heparan sulfate, chondroitin sulfate, and dermatan sulfate based on monosaccharide quantification, CE, heparin lyase digestion, and liquid chromatography/mass spectrometry analysis. Since currently recommended heparin quality control assays had failed to detect certain heparin contaminants, a simple method that detects most contaminants in heparin was developed. This assay detects specific heparin structures that most contaminants cannot mimic and can be performed in any laboratory equipped with an UV spectrometer.

Entities:  

Year:  2010        PMID: 20657729      PMCID: PMC2909132     

Source DB:  PubMed          Journal:  Glycobiol Insights


  26 in total

1.  Contaminated heparin.

Authors:  Andreas Greinacher; Theodore E Warkentin
Journal:  N Engl J Med       Date:  2008-09-18       Impact factor: 91.245

2.  Disaccharide structure code for the easy representation of constituent oligosaccharides from glycosaminoglycans.

Authors:  Roger Lawrence; Hong Lu; Robert D Rosenberg; Jeffrey D Esko; Lijuan Zhang
Journal:  Nat Methods       Date:  2008-04       Impact factor: 28.547

Review 3.  Chemical derivatization as a strategy to study structure-activity relationships of glycosaminoglycans.

Authors:  Benito Casu; Annamaria Naggi; Giangiacomo Torri
Journal:  Semin Thromb Hemost       Date:  2002-08       Impact factor: 4.180

4.  Evolutionary differences in glycosaminoglycan fine structure detected by quantitative glycan reductive isotope labeling.

Authors:  Roger Lawrence; Sara K Olson; Robert E Steele; Lianchun Wang; Rahul Warrior; Richard D Cummings; Jeffrey D Esko
Journal:  J Biol Chem       Date:  2008-09-24       Impact factor: 5.157

5.  Analysis of crude heparin by (1)H NMR, capillary electrophoresis, and strong-anion-exchange-HPLC for contamination by over sulfated chondroitin sulfate.

Authors:  David A Keire; Michael L Trehy; John C Reepmeyer; Richard E Kolinski; Wei Ye; Jamie Dunn; Benjamin J Westenberger; Lucinda F Buhse
Journal:  J Pharm Biomed Anal       Date:  2009-10-30       Impact factor: 3.935

6.  Outbreak of adverse reactions associated with contaminated heparin.

Authors:  David B Blossom; Alexander J Kallen; Priti R Patel; Alexis Elward; Luke Robinson; Ganpan Gao; Robert Langer; Kiran M Perkins; Jennifer L Jaeger; Katie M Kurkjian; Marilyn Jones; Sarah F Schillie; Nadine Shehab; Daniel Ketterer; Ganesh Venkataraman; Takashi Kei Kishimoto; Zachary Shriver; Ann W McMahon; K Frank Austen; Steven Kozlowski; Arjun Srinivasan; George Turabelidze; Carolyn V Gould; Matthew J Arduino; Ram Sasisekharan
Journal:  N Engl J Med       Date:  2008-12-03       Impact factor: 91.245

Review 7.  Heparin-induced thrombocytopenia: impact of bovine versus porcine heparin in HIT pathogenesis.

Authors:  Sarfraz Ahmad
Journal:  Front Biosci       Date:  2007-05-01

8.  Analysis of pharmaceutical heparins and potential contaminants using (1)H-NMR and PAGE.

Authors:  Zhenqing Zhang; Boyangzi Li; Jiraporn Suwan; Fuming Zhang; Zhenyu Wang; Haiying Liu; Barbara Mulloy; Robert J Linhardt
Journal:  J Pharm Sci       Date:  2009-11       Impact factor: 3.534

9.  Orthogonal analytical approaches to detect potential contaminants in heparin.

Authors:  Marco Guerrini; Zhenqing Zhang; Zachary Shriver; Annamaria Naggi; Sayaka Masuko; Robert Langer; Benito Casu; Robert J Linhardt; Giangiacomo Torri; Ram Sasisekharan
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-23       Impact factor: 11.205

Review 10.  Survival of heparins, oral anticoagulants, and aspirin after the year 2010.

Authors:  Jawed Fareed; Debra A Hoppensteadt; Daniel Fareed; Muzaffer Demir; Rakesh Wahi; Melaine Clarke; Cafer Adiguzel; Rodger Bick
Journal:  Semin Thromb Hemost       Date:  2008-02       Impact factor: 4.180

View more
  5 in total

1.  Fluorescent liposomes for differential interactions with glycosaminoglycans.

Authors:  Erin K Nyren-Erickson; Manas K Haldar; Yan Gu; Steven Y Qian; Daniel L Friesner; Sanku Mallik
Journal:  Anal Chem       Date:  2011-06-30       Impact factor: 6.986

2.  Oversulfated chondroitin sulfate is not the sole contaminant in heparin.

Authors:  Jing Pan; Yi Qian; Xiaodong Zhou; Andrew Pazandak; Sarah B Frazier; Peter Weiser; Hong Lu; Lijuan Zhang
Journal:  Nat Biotechnol       Date:  2010-03       Impact factor: 54.908

3.  Mass balance analysis of contaminated heparin product.

Authors:  Zhenling Liu; Zhongping Xiao; Sayaka Masuko; Wenjing Zhao; Eric Sterner; Vinod Bansal; Jawed Fareed; Jonathan Dordick; Fuming Zhang; Robert J Linhardt
Journal:  Anal Biochem       Date:  2010-09-17       Impact factor: 3.365

4.  Chemically oversulfated glycosaminoglycans are potent modulators of contact system activation and different cell signaling pathways.

Authors:  Jing Pan; Yi Qian; Xiaodong Zhou; Hong Lu; Eduardo Ramacciotti; Lijuan Zhang
Journal:  J Biol Chem       Date:  2010-04-23       Impact factor: 5.157

5.  Method to detect contaminants in heparin using radical depolymerization and liquid chromatography-mass spectrometry.

Authors:  Guoyun Li; Chao Cai; Lingyun Li; Li Fu; Yuqing Chang; Fuming Zhang; Toshihiko Toida; Changhu Xue; Robert J Linhardt
Journal:  Anal Chem       Date:  2013-12-23       Impact factor: 6.986

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.